The Glycosylation of Serum IgG Antibodies in Post-COVID-19 and Post-Vaccination Patients

Overview

Journal Int J Mol Sci

Publisher MDPI

Date 2025 Jan 25

PMID 39859521

Authors

Csaba Varadi

Affiliations

Soon will be listed here.

Abstract

The signature of human serum IgG glycosylation is critical in the defense against pathogens. Alterations of IgG N-glycome were associated with COVID-19 (Coronavirus disease 2019) severity, although knowledge on the response to vaccination is limited. IgG N-glycome was analyzed in this study in post-COVID-19 and post-vaccination patients to reveal potential glycosylation-based alterations using hydrophilic interaction liquid chromatography (HILIC-UPLC) with fluorescence (FLR) and mass-spectrometric (MS) detection. IgG antibodies were purified from serum samples through protein G affinity chromatography followed by PNGase F digestion-based deglycosylation. The released glycans were fluorescently derivatized by procainamide labeling and purified via solid-phase extraction. Higher levels of sialylation and afucosylation were identified in post-COVID-19 patients, which was further expanded by vaccination, but only in those who were previously SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) infected.

References

Murin C, Wilson I, Ward A . Antibody responses to viral infections: a structural perspective across three different enveloped viruses. Nat Microbiol. 2019; 4(5):734-747. PMC: 6818971. DOI: 10.1038/s41564-019-0392-y. View

Hou H, Yang H, Liu P, Huang C, Wang M, Li Y . Profile of Immunoglobulin G -Glycome in COVID-19 Patients: A Case-Control Study. Front Immunol. 2021; 12:748566. PMC: 8495247. DOI: 10.3389/fimmu.2021.748566. View

Beimdiek J, Janciauskiene S, Wrenger S, Volland S, Rozy A, Fuge J . Plasma markers of COVID-19 severity: a pilot study. Respir Res. 2022; 23(1):343. PMC: 9745704. DOI: 10.1186/s12931-022-02272-7. View

Vidarsson G, Dekkers G, Rispens T . IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014; 5:520. PMC: 4202688. DOI: 10.3389/fimmu.2014.00520. View

Ash M, Bhimalli P, Cho B, Mattamana B, Gambut S, Tarhoni I . Bulk IgG glycosylation predicts COVID-19 severity and vaccine antibody response. Cell Rep. 2022; 41(11):111799. PMC: 9678812. DOI: 10.1016/j.celrep.2022.111799. View

Zhao J, Nussinov R, Ma B . Antigen binding allosterically promotes Fc receptor recognition. MAbs. 2018; 11(1):58-74. PMC: 6343797. DOI: 10.1080/19420862.2018.1522178. View

Reily C, Stewart T, Renfrow M, Novak J . Glycosylation in health and disease. Nat Rev Nephrol. 2019; 15(6):346-366. PMC: 6590709. DOI: 10.1038/s41581-019-0129-4. View

Shantha Raju T . Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol. 2008; 20(4):471-8. DOI: 10.1016/j.coi.2008.06.007. View

Petrovic T, Vijay A, Vuckovic F, Trbojevic-Akmacic I, Ollivere B, Marjanovic D . IgG N-glycome changes during the course of severe COVID-19: An observational study. EBioMedicine. 2022; 81:104101. PMC: 9234382. DOI: 10.1016/j.ebiom.2022.104101. View

10.

Farkash I, Feferman T, Cohen-Saban N, Avraham Y, Morgenstern D, Mayuni G . Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern. Cell Rep. 2021; 37(11):110114. PMC: 8610888. DOI: 10.1016/j.celrep.2021.110114. View

11.

Boune S, Hu P, Epstein A, Khawli L . Principles of -Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations. Antibodies (Basel). 2020; 9(2). PMC: 7345016. DOI: 10.3390/antib9020022. View

12.

Irvine E, Alter G . Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases. Glycobiology. 2020; 30(4):241-253. PMC: 7109349. DOI: 10.1093/glycob/cwaa018. View

13.

Shkunnikova S, Mijakovac A, Sironic L, Hanic M, Lauc G, Kavur M . IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy. Biotechnol Adv. 2023; 67:108169. DOI: 10.1016/j.biotechadv.2023.108169. View

14.

Kristic J, Lauc G . The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals. Immunol Rev. 2024; 328(1):143-170. PMC: 11659926. DOI: 10.1111/imr.13407. View

15.

Chakraborty S, Gonzalez J, Sievers B, Mallajosyula V, Chakraborty S, Dubey M . Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Sci Transl Med. 2022; 14(635):eabm7853. PMC: 8939764. DOI: 10.1126/scitranslmed.abm7853. View

16.

Nicholson L . The immune system. Essays Biochem. 2016; 60(3):275-301. PMC: 5091071. DOI: 10.1042/EBC20160017. View

17.

Schroeder Jr H, Cavacini L . Structure and function of immunoglobulins. J Allergy Clin Immunol. 2010; 125(2 Suppl 2):S41-52. PMC: 3670108. DOI: 10.1016/j.jaci.2009.09.046. View

18.

Pongracz T, Vidarsson G, Wuhrer M . Antibody glycosylation in COVID-19. Glycoconj J. 2022; 39(3):335-344. PMC: 8799414. DOI: 10.1007/s10719-022-10044-0. View